V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220001628 | 220010324 | null | null | null | null | 2019-02-10 | null | null | null | TRIAL UNSPECIFIED | 101128745 |
| 220001629 | 220010325 | 1.88 | 72 | null | null | 2019-08-01 | Lomustine | null | null | LOMUSTINE | 100569480 |
| 220001650 | 220010330 | 1.65 | 55.8 | null | null | 2021-11-09 | null | null | null | STS RHABDOMYOSARCOMA RMS 2005 IVA | 101631427 |
| 220001651 | 220010331 | null | null | Palliative (P) | 2016-07-09 | 2016-07-16 | null | 02 | N | CNS VINILO (TRIAL) WEEKLY VINBLASTINE | 101225835 |
| 220001683 | 220010340 | null | null | null | 2017-04-14 | 2017-04-14 | Temozolomide + RT | 02 | null | CNS HGG TEMOZOLOMIDE +XRT | 100638901 |
| 220001691 | 220010344 | null | null | null | null | 2022-01-23 | null | 02 | null | CNS VINILO (TRIAL) WEEKLY VINBLASTINE | 101630513 |
| 220001714 | 220010348 | null | null | null | null | 2018-12-25 | Temozolomide + RT | null | null | TEMOZOLOMIDE + RT | 101607208 |
| 220001721 | 220010350 | 0 | 16.3 | null | null | 2017-02-27 | null | null | null | CNS LGG 2004 03 VINC WEEKLY+ CARBO | 100169494 |
| 220001741 | 220010356 | 1.73 | 73 | null | null | 2018-12-07 | IPILIMUMAB + NIVOLUMAB | null | null | CNS HGG TEMOZOLOMIDE +XRT | 101497876 |
| 220001746 | 220010360 | 1.66 | 105.8 | null | null | 2019-07-29 | CNS LGG 2004 03 cons vinc + carbo | null | null | CNS VINILO (TRIAL) WEEKLY VINBLASTINE | 101473385 |
| 220001763 | 220010364 | 1.71 | 78.7 | null | null | 2018-08-18 | CARBOPLATIN | null | null | CNS INFANT HGG VINCRISTINE/CYCLOPHOSPHAMIDE | 101608336 |
| 220001765 | 220010365 | 1.85 | 119.8 | null | null | 2017-12-14 | CNS Headstart II A Ind 1,2,3 no int | null | null | LOMUSTINE + PROCARBAZINE + VINCRISTINE | 100583987 |
| 220001768 | 220010367 | 1.78 | 68.45 | null | null | 2018-10-17 | CNS LGG 2004 03 cons vinc + carbo | null | null | LOMUSTINE + PROCARBAZINE + VINCRISTINE | 101745761 |
| 220001796 | 220010374 | null | null | Adjuvant (A) | 2018-07-06 | 2018-07-11 | null | 02 | N | STS RHABDOMYOSARCOMA RMS 2005 IVA | 101791749 |
| 220001806 | 220010378 | null | null | null | null | 2016-10-13 | CARBOPLATIN | null | null | CNS HGG TEMOZOLOMIDE +XRT | 100537342 |
| 220001809 | 220010380 | null | null | Adjuvant (A) | 2019-08-13 | 2019-08-13 | CNS VINILO (trial) Weekly Vinblastine | 02 | N | LOMUSTINE + PROCARBAZINE + VINCRISTINE | 101527338 |
| 220001815 | 220010383 | null | null | null | null | 2016-07-14 | CARBOPLATIN | null | null | BEVACIZUMAB + IRINOTECAN | 101739519 |
| 220001822 | 220010384 | 1.73 | 61.3 | null | null | 2019-01-17 | Temozolomide + RT | null | null | TEMOZOLOMIDE + RT | 101468827 |
| 220001825 | 220010385 | 1.83 | 87.4 | null | null | 2020-09-28 | CARBOPLATIN + VINCRISTINE | null | null | TEMOZOLOMIDE + RT | 100761257 |
| 220001827 | 220010386 | 1.83 | 89 | null | 2017-02-27 | 2017-06-27 | null | 02 | null | CNS LOW GRADE GLIOMA VINBLASTINE | 101029771 |
| 220001842 | 220010389 | null | null | null | null | 2019-08-27 | null | null | null | CNS LGG 2004 03 VINC WEEKLY+ CARBO | 101790071 |
| 220001846 | 220010391 | 1.58 | 110 | Curative (C) | 2021-05-18 | 2021-05-23 | null | 02 | N | CNS INFANT HGG VINCRISTINE/CYCLOPHOSPHAMIDE | 100244512 |
| 220001849 | 220010392 | null | null | Palliative (P) | 2016-06-12 | 2016-06-13 | null | 02 | N | CNS LGG2004 03 VINC + CARBO | 100646055 |
| 220001861 | 220010395 | null | null | Palliative (P) | 2017-06-15 | 2017-06-23 | Temozolomide + RT | 02 | N | TEMOZOLOMIDE + RT | 100047177 |
| 220001866 | 220010397 | null | null | Palliative (P) | 2017-06-03 | 2017-06-03 | null | 02 | N | LOMUSTINE + PROCARBAZINE + VINCRISTINE | 100588683 |
| 220001867 | 220010398 | 1.58 | 71.2 | null | 2019-05-28 | 2019-07-13 | PCV | 02 | null | LOMUSTINE + PROCARBAZINE + VINCRISTINE | 101616748 |
| 220001889 | 220010404 | null | null | null | null | 2020-04-16 | PCV | null | null | LOMUSTINE + PROCARBAZINE + VINCRISTINE | 100324851 |
| 220001890 | 220010405 | 1.67 | 67.6 | null | null | 2017-12-25 | PCV | null | null | LOMUSTINE + PROCARBAZINE + VINCRISTINE | 100440081 |
| 220001897 | 220010408 | 0 | 12.7 | null | null | 2019-12-07 | NIVOLUMAB | null | null | PCV | 101718741 |
| 220001921 | 220010412 | null | null | null | null | 2019-05-02 | PCV | null | null | LOMUSTINE + PROCARBAZINE + VINCRISTINE | 101468754 |
| 220001925 | 220010413 | null | null | null | null | 2019-06-04 | Trial Unspecified | null | null | LOMUSTINE + PROCARBAZINE + VINCRISTINE | 100896067 |
| 220001932 | 220010417 | 1.93 | 77.7 | Curative (C) | 2016-07-18 | 2016-07-18 | null | 02 | N | LOMUSTINE | 101100163 |
| 220001938 | 220010419 | null | null | null | null | 2019-03-10 | IPILIMUMAB + NIVOLUMAB | null | null | CNS EPENDY II VINC/CARBO | 100703222 |
| 220001941 | 220010420 | 1.8 | 119.4 | null | null | 2017-12-20 | Trial Unspecified | null | null | CNS LGG 2004 03 VINC WEEKLY+ CARBO | 100110582 |
| 220001963 | 220010423 | null | null | null | null | 2018-01-27 | null | null | null | CNS LGG 2004 03 CONS VINC + CARBO | 100648272 |
| 220001966 | 220010424 | null | null | null | null | 2020-12-24 | PCV | null | null | LOMUSTINE + PROCARBAZINE + VINCRISTINE | 100829575 |
| 220001975 | 220010427 | null | null | Adjuvant (A) | null | 2018-12-31 | null | N | N | CNS LGG 2004 03 VINC WEEKLY+ CARBO | 100494364 |
| 220001977 | 220010428 | null | null | null | null | 2019-07-04 | CARBOPLATIN + ETOPOSIDE | null | null | TEMOZOLOMIDE + RT | 101460241 |
| 220001980 | 220010429 | 1.74 | 98 | Palliative (P) | 2020-11-07 | 2020-11-07 | null | 02 | N | TEMOZOLOMIDE + RT | 100542253 |
| 220002003 | 220010432 | 1.77 | 80.9 | null | null | 2017-03-01 | Lomustine | null | null | LOMUSTINE | 101530900 |
| 220002004 | 220010433 | 0 | 12 | null | null | 2016-10-20 | NIVOLUMAB | null | null | CNS LGG BEVACIZUMAB & IRINOTECAN | 101775061 |
| 220002016 | 220010436 | null | null | null | null | 2020-11-24 | PCV | null | null | LOMUSTINE + PROCARBAZINE + VINCRISTINE | 100090916 |
| 220002044 | 220010440 | 0 | 6.8 | null | null | 2016-07-25 | Temozolomide + RT | null | null | TEMOZOLOMIDE + RT | 100748092 |
| 220002047 | 220010442 | 1.84 | 89.5 | Adjuvant (A) | 2019-10-10 | 2019-10-31 | Trial Unspecified | 02 | N | PCV | 100596864 |
| 220002051 | 220010444 | null | null | 03 | 2016-10-18 | 2016-10-18 | null | 02 | Y | STS RHABDOMYOSARCOMA RMS 2005 IVA | 101525499 |
| 220002062 | 220010447 | 1.6 | 76.4 | null | null | 2020-10-23 | PCV | null | null | LOMUSTINE + PROCARBAZINE + VINCRISTINE | 100429699 |
| 220002068 | 220010449 | 1.46 | 84 | null | null | 2017-12-12 | null | null | null | TEMOZOLOMIDE + RT | 100716397 |
| 220002160 | 220010460 | 1.57 | 64.8 | null | null | 2019-10-18 | null | null | null | CNS LGG2004 03 VINC + CARBO | 101640756 |
| 220002183 | 220010464 | 1.65 | 77.9 | null | null | 2019-09-02 | PCV | null | null | LOMUSTINE + PROCARBAZINE + VINCRISTINE | 100157718 |
| 220002204 | 220010466 | 1.82 | 147 | null | null | 2017-06-10 | CNS Low Grade Glioma Vinblastine | null | null | TEMOZOLOMIDE + RT | 100850032 |